Biobank for multidrug-resistant tuberculosis research: importance of sequential samples

Area of Science:

• Microbiology
• Infectious Diseases
• Clinical Research

Background:

• Tuberculosis (TB) remains a significant global health challenge.
• The emergence of multidrug-resistant tuberculosis (MDR-TB) necessitates advanced research.
• Standardized sample collection is crucial for understanding disease progression and treatment efficacy.

Purpose of the Study:

• To establish and maintain a comprehensive repository of tuberculosis patient samples.
• To facilitate international research collaborations on TB and MDR-TB.
• To provide longitudinal data on patient bacilli and treatment responses.

Main Methods:

• Systematic collection of standardized patient specimens since 2013.
• Inclusion of matched participant data and sequential bacilli samples.
• Focus on patients undergoing tuberculosis treatment.

Main Results:

• Accumulation of a substantial collection of TB patient samples.
• Inclusion of a significant number of multidrug-resistant strains.
• Establishment of a longitudinal dataset tracking treatment progression.

Conclusions:

• The Masan National Tuberculosis Hospital repository serves as a valuable resource for TB research.
• The collected samples, particularly MDR-TB strains, are vital for developing new diagnostic and therapeutic strategies.
• This initiative supports global efforts to combat tuberculosis through collaborative research.